Process for the preparation of 1,5-benzothiazepine compounds
The present invention relates to a process for the preparation of certain 1,5-benzothiazepine compounds, and in particular to a process for the preparation of elobixibat. The process can be carried out under mild and safe conditions and may be used to prepare elobixibat on an industrial scale. The invention also relates to a process for the preparation of a crystalline monohydrate of elobixibat.
1. A process for the preparation of a compound of formula (I):
comprising reacting a compound of formula (II):
with a compound of formula (III):
wherein
R 6 is a suitable protecting group;
to obtain a compound of formula (IV):
and deprotecting said compound of formula (IV) to obtain the compound of formula (I).
2. The process according to claim 1 , wherein R 6 is selected from the group consisting of C 1-4 alkyl and trisubstituted silyl.
3. The process according to claim 1 , wherein R 6 is tert-butyl.
4. The process according to claim 1 , wherein the reaction between the compounds of formulas (II) and (III) is performed in the presence of 2,6-lutidine.
5. The process according to claim 1 , wherein the compound of formula (IV) is recrystallized from acetonitrile.
6. The process according to claim 1 , wherein the hydrolysis of the compound of formula (IV) is performed in toluene.
7. The process according to claim 1 , wherein the compound of formula (I) is precipitated from a solution by the addition of heptane.
8. The process according to claim 1 , wherein the compound of formula (II) is prepared by an alkylation reaction comprising reacting a compound of formula (V):
with a compound of formula (VI):
wherein
R 7 is a suitable protecting group; and
X is a suitable leaving group;
to obtain an intermediate compound of formula (VII):
followed by hydrolysis of the ester R 7 O—C(O)—,
to obtain the compound of formula (II).
9. The process according to claim 8 , wherein R 7 is selected from the group consisting of C 1-4 alkyl and C 1-4 haloalkyl.
10. The process according to claim 8 , wherein X is selected from the group consisting of halo, trifluoromethanesulfonate, methanesulfonyl and p-toluenesulfonyl.
11. The process according to claim 8 , wherein the compound of formula (II) is first precipitated as the corresponding sodium salt and thereafter protonated and crystallized.
12. The process according to claim 8 , wherein the preparation of the intermediate compound of formula (VII) is performed in toluene.
13. The process according to claim 8 , wherein the intermediate compound of formula (VII) is not isolated but used immediately in the next step.
14. The process according to claim 8 , wherein the alkylation reaction and the subsequent hydrolysis reaction are performed in the same solvent.
15. The process according to claim 1 , further comprising transforming the compound of formula (I) into a stable crystalline hydrate of formula (I).
16. The process according to claim 15 , wherein the compound of formula (I) is dissolved in a mixture of ethanol and ethyl acetate.
17. The process according to claim 15 , wherein n-heptane is added to the solution of the compound of formula (I) in the mixture of ethanol and ethyl acetate.
18. The process according to claim 15 , wherein the stable crystalline hydrate is a crystalline monohydrate.
19. A process for the preparation of a crystal modification IV of elobixibat, comprising the steps of:
(i) dissolving crude elobixibat in a mixture of ethanol and ethyl acetate;
(ii) crystallizing a crystalline ethanolate of elobixibat from the solution of crude elobixibat in the mixture of ethanol and ethyl acetate obtained in step (i);
(iii) drying the crystalline ethanolate of elobixibat to obtain a crystalline anhydrate of elobixibat; and
(iv) hydrating the crystalline anhydrate of elobixibat to obtain crystal modification IV of elobixibat.
20. The process according to claim 19 , wherein in step (ii) n-heptane is added to the solution of crude elobixibat in the mixture of ethanol and ethyl acetate.